Pardeep Nijhawan bought $20k of EDSA
Chief Executive Officer at Edesa Biotech, Inc.. 5,000 shares at an average of $4.00, traded Mar 25, 2024, filed Mar 25, 2024.
Score components
- +25RoleCEO
- 0Trade size$20k at market
- 0Relative to holdingsHoldings up 1.5%
- +8Price context49% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001654954-24-003606, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 25, 2024 | POpen-market purchase Common Sharesindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +5,000 | $4.00 | $20k | 341,702 | Mar 25, 2024 |
Related signals
Other insiders at Edesa Biotech, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | Edesa Biotech, Inc. | Michael J Brooks President | $3,140 2,000 shares | +1% | |
| 33Weak | Edesa Biotech, Inc. | Pardeep Nijhawan Chief Executive Officer | $6,599 1,000 shares | +0% | |
| 44Moderate | Edesa Biotech, Inc. | Pardeep Nijhawan Chief Executive Officer | $39k 10,000 shares | +3% | |
| 44Moderate | Edesa Biotech, Inc. | Pardeep Nijhawan Chief Executive Officer | $43k 10,000 shares | +3% | |
| 44Moderate | Edesa Biotech, Inc. | Pardeep Nijhawan Chief Executive Officer | $36k 10,000 shares | +3% | |
| 33Weak | Edesa Biotech, Inc. | Pardeep Nijhawan Chief Executive Officer | $6,280 3,000 shares | +0% | |
| 46Moderate | Edesa Biotech, Inc. | Pardeep Nijhawan Chief Executive Officer | $99k 50,571 shares | +8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.